Schizophrenia and Disorders With Psychotic Features
19
2
2
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.3%
1 terminated out of 19 trials
92.9%
+6.4% vs benchmark
16%
3 trials in Phase 3/4
23%
3 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (19)
Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
Karolinska Schizophrenia Project
Effectiveness of a Mindfulness-based Group Training Addressing Social Cognition in First Episode Psychosis (AGES-Mind)
Video Games Among People With Schizophrenia
Side Effects of Antipsychotic Medications
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents
The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy Motivation
Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study
Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia
Specialized Treatment Early in Psychosis (STEP)
Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2
Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
Investigator Initiated Study - Asenapine Early Psychosis
Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland
Social Skills Training in Refractory Schizophrenia